Company news
Canntab Therapeutics Limited news in 2018
Canntab Therapeutics Limited's news releases, calls and decks from 2018, newest first.
InvestmentPitch Media Video Discusses Canntab Therapeutics and its Application to Become a Licensed Producer Under ACMPR with Health Canada - Video News Alert on Investmentpitch.com
October 22, 2018
Canntab Files Application to Become Licensed Producer
October 18, 2018
Canntab Therapeutics, Extended Release Cannabis Tablets, CEO Clip Video
October 4, 2018
InvestmentPitch Media Video Discusses Canntab Therapeutics LOI With NewCanna of Colombia to Distribute Canntab Products in Select Countries - Video News Alert on Investmentpitch.com
October 4, 2018
Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply
October 1, 2018
Canntab Added to CSE Composite Index
September 24, 2018
Canntab Sets New All-Time High Trading Prices and Volume
September 20, 2018
Canntab Exceeds All-Time High Trading Prices and Grants Options
September 19, 2018
Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials
September 18, 2018
Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for Production and Market of Oral Dose Delivery Platforms
September 18, 2018
Canntab Engages Industry Leader Lorne Gertner as Consultant
July 16, 2018
InvestmentPitch Media Video Discusses Canntab Therapeutics LOI with FSD Pharma to Obtain License to Process and Sell Cannabis Based Products - Video News Alert on Investmentpitch.com
July 11, 2018
Canntab announces collaboration and profit sharing agreement with FSD Pharma to produce and market oral dose delivery platforms
July 9, 2018
Canntab Announces Launch of Innovative Hemp Oil Capsules
June 20, 2018
Canntab Announces Director Resignation
June 14, 2018
Canntab Therapeutics Files 2 New Canadian Patent Applications Related to Pharmaceutical Cannabis
May 25, 2018
Canntab Appoints Bob Woloschuk to Advisory Board
May 17, 2018
Canntab Provides Clarification on CFN Media Engagement
May 15, 2018
Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation
May 14, 2018
Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis
April 26, 2018
Canntab Provides Corporate Update
April 24, 2018